Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7182537rdf:typepubmed:Citationlld:pubmed
pubmed-article:7182537lifeskim:mentionsumls-concept:C0009450lld:lifeskim
pubmed-article:7182537lifeskim:mentionsumls-concept:C0008972lld:lifeskim
pubmed-article:7182537lifeskim:mentionsumls-concept:C0007558lld:lifeskim
pubmed-article:7182537lifeskim:mentionsumls-concept:C1521738lld:lifeskim
pubmed-article:7182537pubmed:issue12lld:pubmed
pubmed-article:7182537pubmed:dateCreated1983-7-8lld:pubmed
pubmed-article:7182537pubmed:abstractTextThe clinical effect of cefsulodin (CFS) on Pseudomonas species infections in otorhinolaryngologic field was studied in 10 patients. The overall clinical effectiveness was 80% (excellent 4, good 4, poor 2). The bacteriological response of CFS against Pseudomonas species was evaluated from 11 strains. Eradication rate of Pseudomonas species was 82%. In 1 case, body temperature was rised after injection. No abnormal laboratory findings, relating to the drug, were observed after treatment.lld:pubmed
pubmed-article:7182537pubmed:languagejpnlld:pubmed
pubmed-article:7182537pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7182537pubmed:citationSubsetIMlld:pubmed
pubmed-article:7182537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7182537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7182537pubmed:statusMEDLINElld:pubmed
pubmed-article:7182537pubmed:monthDeclld:pubmed
pubmed-article:7182537pubmed:issn0368-2781lld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:SatoFFlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:NishimuraTTlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:SaitoHHlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:TachibanaMMlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:SaitoAAlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:NakamuraAAlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:MizukoshiOOlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:MatsuokaHHlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:OkawaKKlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:MizukoshiFFlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:YanoharaKKlld:pubmed
pubmed-article:7182537pubmed:authorpubmed-author:TakenouchiSSlld:pubmed
pubmed-article:7182537pubmed:issnTypePrintlld:pubmed
pubmed-article:7182537pubmed:volume35lld:pubmed
pubmed-article:7182537pubmed:ownerNLMlld:pubmed
pubmed-article:7182537pubmed:authorsCompleteYlld:pubmed
pubmed-article:7182537pubmed:pagination2831-4lld:pubmed
pubmed-article:7182537pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:meshHeadingpubmed-meshheading:7182537-...lld:pubmed
pubmed-article:7182537pubmed:year1982lld:pubmed
pubmed-article:7182537pubmed:articleTitle[Clinical study of cefsulodin on infectious diseases in otorhinolaryngological field].lld:pubmed
pubmed-article:7182537pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7182537pubmed:publicationTypeEnglish Abstractlld:pubmed